PPARδ/γ agonist 1 sodium is a chemically unique and brain penetrant dual PPAR delta/gamma agonist. PPARδ/γ agonist 1 sodium can be used for the research of Alzheimer’s disease.In VivoPPARδ/γ agonist 1 sodium (1 mg/kg; i.g. once daily for 16 days) restores STZ-mediated impairments of motor function . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: STZ-mediated Long Evans rats Dosage: 1 mg/kg Administration: Oral gavage; 1 mg/kg once daily, for 16 days Result: Improved performance in STZ-mediated rats and showed neuroprotective for both granule and Purkinje cells.Form:Solid. Specification: 0.99 Molecular Formula: C25H26NNaO5 Molecular Weight: 443.47 PubChem CID: 49839871 Isomeric SMILES: CCC1=C(N=C(O1)C2=CC=C(C=C2)OC)CCOC3=CC4=C(C=C3)[C@@H](CC4)CC(=O)[O-].[Na+]
- UPC:
- 51141587
- Condition:
- New
- Availability:
- 8-12 weeks
- Weight:
- 1.06 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- P648592-5mg
- CAS:
- 1258076-66-2
- Product Size:
- 5mg
